Dr. Robert An-Kuo Lee, MD, PhD

Dr. Lee practices at 3883 Airway Drive Imaging in Santa Rosa, California.

Dr. Lee's NPI, 1346300274, was assigned on December 11, 2006. Dr. Lee graduated from David Geffen School of Medicine at UCLA in 2003. Dr. Lee's California license number on file is 874491.

Dr. Lee's primary practice is 3883 Airway Drive Imaging, at 3883 Airway Dr. Ste 100, Santa Rosa, CA 95403. The practice phone is (707) 521-4480.

Dr. Lee's primary practice is 3883 Airway Drive Imaging in Santa Rosa, California. Dr. Lee is also affiliated with California Pacific Medical Center Davies Campus. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Lee to 1 more group practice or clinic, named with a free account. Dr. Lee's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatopathology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207ND0900X. Dr. Lee is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Lee's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists acute skin infection, benign or precancerous skin growths, contact dermatitis, hives, itchy rashes, minor injury to a limb, psoriasis and rash among the conditions Dr. Lee treats.

CMS data shows 3,083 Medicare services from Dr. Lee across 19 procedure codes in 2024, for 987 Medicare patients. Medicare paid $141,271 for them. Every service was in an office.

CMS counts 987 Medicare patients who saw Dr. Lee in 2024. The largest group is 65 to 74, with 474 patients. 71% of them have high cholesterol, and 59% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 72, with 47% women.

In 2024, Dr. Lee wrote 757 Medicare Part D claims for 278 patients. 92% of them were for generic drugs. CMS names the drug for 630 of them, across 20 drugs with 11 or more claims each, at $149,806 in total drug cost. In 2023, CMS named 656 claims across 22 drugs.

Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 419 procedures of removal of skin lesions by Dr. Lee, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Lee in 2021. 2021 was the busiest year, with 2. Dr. Lee has published most often in Eur Phys J C Part Fields. Dr. Lee's most frequent co-authors are Jasvinder Singh, Philip R. Cohen, MD and Shivali Malhotra, MD.

Dmand AI links Dr. Lee to 1 clinical trial. Conditions studied include Hidradenitis Suppurativa and Hidradenitis.

CMS Open Payments shows 10 general payments to Dr. Lee from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Celgene Corporation paid the most, $140.

Dmand AI lists 2 awards for Dr. Lee, most recently CMS Stage 1 EHR in 2013.

Dr. Lee graduated from David Geffen School of Medicine at UCLA in 2003. Dr. Lee is a member of AAD.

Dr. Lee is in network with 12 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.